Literature DB >> 27826159

Prescribing of Direct Oral Anticoagulants in Atrial Fibrillation Based on Estimation of Renal Function Using Standard and Modified Cockcroft-Gault Equations: A Retrospective Analysis.

Melissa Kucey1, Jennifer Bolt2, Lori Albers3, Ali Bell4, Nkem Iroh5, Julie Toppings1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27826159      PMCID： PMC5085326          DOI： 10.4212/cjhp.v69i5.1596

Source DB:  PubMed          Journal:  Can J Hosp Pharm        ISSN： 0008-4123


× No keyword cloud information.
  17 in total

1.  The gap between trial data and clinical practice -- an analysis of case reports on bleeding complications occurring under dabigatran and rivaroxaban anticoagulation.

Authors:  Waltraud Pfeilschifter; Sebastian Luger; Robert Brunkhorst; Edelgard Lindhoff-Last; Christian Foerch
Journal:  Cerebrovasc Dis       Date:  2013-09-11       Impact factor: 2.762

2.  2014 focused update of the Canadian Cardiovascular Society Guidelines for the management of atrial fibrillation.

Authors:  Atul Verma; John A Cairns; L Brent Mitchell; Laurent Macle; Ian G Stiell; David Gladstone; Michael Sean McMurtry; Stuart Connolly; Jafna L Cox; Paul Dorian; Noah Ivers; Kori Leblanc; Stanley Nattel; Jeff S Healey
Journal:  Can J Cardiol       Date:  2014-08-13       Impact factor: 5.223

Review 3.  Novel oral anticoagulants in patients with renal insufficiency: a meta-analysis of randomized trials.

Authors:  Partha Sardar; Saurav Chatterjee; Eyal Herzog; Ramez Nairooz; Debabrata Mukherjee; Jonathan L Halperin
Journal:  Can J Cardiol       Date:  2014-04-18       Impact factor: 5.223

4.  Assessment of dabigatran utilization and prescribing patterns for atrial fibrillation in a physician group practice setting.

Authors:  Blake Carley; Sara Griesbach; Tonja Larson; Kori Krueger
Journal:  Am J Cardiol       Date:  2013-11-23       Impact factor: 2.778

5.  Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm control.

Authors:  Allan C Skanes; Jeff S Healey; John A Cairns; Paul Dorian; Anne M Gillis; M Sean McMurtry; L Brent Mitchell; Atul Verma; Stanley Nattel
Journal:  Can J Cardiol       Date:  2012 Mar-Apr       Impact factor: 5.223

6.  Comparison of creatinine clearance estimation methods in patients with trauma.

Authors:  G A Davis; M H Chandler
Journal:  Am J Health Syst Pharm       Date:  1996-05-01       Impact factor: 2.637

7.  European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation.

Authors:  Hein Heidbuchel; Peter Verhamme; Marco Alings; Matthias Antz; Werner Hacke; Jonas Oldgren; Peter Sinnaeve; A John Camm; Paulus Kirchhof
Journal:  Europace       Date:  2013-05       Impact factor: 5.214

8.  Dabigatran versus warfarin in patients with atrial fibrillation.

Authors:  Stuart J Connolly; Michael D Ezekowitz; Salim Yusuf; John Eikelboom; Jonas Oldgren; Amit Parekh; Janice Pogue; Paul A Reilly; Ellison Themeles; Jeanne Varrone; Susan Wang; Marco Alings; Denis Xavier; Jun Zhu; Rafael Diaz; Basil S Lewis; Harald Darius; Hans-Christoph Diener; Campbell D Joyner; Lars Wallentin
Journal:  N Engl J Med       Date:  2009-08-30       Impact factor: 91.245

9.  Stroke severity in atrial fibrillation. The Framingham Study.

Authors:  H J Lin; P A Wolf; M Kelly-Hayes; A S Beiser; C S Kase; E J Benjamin; R B D'Agostino
Journal:  Stroke       Date:  1996-10       Impact factor: 7.914

10.  Early adoption of dabigatran and its dosing in US patients with atrial fibrillation: results from the outcomes registry for better informed treatment of atrial fibrillation.

Authors:  Benjamin A Steinberg; Dajuanicia N Holmes; Jonathan P Piccini; Jack Ansell; Paul Chang; Gregg C Fonarow; Bernard Gersh; Kenneth W Mahaffey; Peter R Kowey; Michael D Ezekowitz; Daniel E Singer; Laine Thomas; Eric D Peterson; Elaine M Hylek
Journal:  J Am Heart Assoc       Date:  2013-11-25       Impact factor: 5.501
View more
  2 in total

1.  Appropriateness of DOAC Prescribing Before and During Hospital Admission and Analysis of Determinants for Inappropriate Prescribing.

Authors:  Souad Moudallel; Stephane Steurbaut; Pieter Cornu; Alain Dupont
Journal:  Front Pharmacol       Date:  2018-10-30       Impact factor: 5.810

2.  Accurate GFR in obesity-protocol for a systematic review.

Authors:  Sriram Sriperumbuduri; Robert Dent; Janine Malcolm; Swapnil Hiremath; Ran Klein; Christine A White; Pierre Antoine Brown; Ayub Akbari
Journal:  Syst Rev       Date:  2019-06-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.